COVID-19: China Healthcare Implications for Private Equity Investors Presentations July 14, 2020 Helen Chen Justin Wang Stephen Sunderland
Related Practice Private Equity We are seeking to drive practical insight from China’s experience to inform healthcare investment 01262022160120
Published Articles Life Sciences & Pharma In need of an all-inclusive trip: socio-demographic diversity in psychedelic research November 8, 2024
Executive Insights Life Sciences & Pharma Preparing for Innovation: A Maturity Framework for Artificial Intelligence in Life… August 2, 2024
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024
Executive Insights Post-Merger Integration Approaches to Building the Leadership Team in a Merger Integration May 16, 2024